Stephen K. Doberstein

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen K. Doberstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Forte Biosciences, Inc. Director Stock Option (right to buy) 31K 20 Mar 2025 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 28 Dec 2021 Direct
Dicerna Pharmaceuticals Inc Director Director Stock Option (Right to Buy) 0 28 Dec 2021 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 28 Dec 2021 Direct

Insider Reports Filed by Stephen K. Doberstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FBRX Forte Biosciences, Inc. 20 Mar 2025 1 $0 4 Director 21 Mar 2025, 16:48
FBRX Forte Biosciences, Inc. 20 Aug 2024 1 $0 4 Director 22 Aug 2024, 16:09
FBRX Forte Biosciences, Inc. 19 Sep 2023 1 $0 4 Director 20 Sep 2023, 17:48
FBRX Forte Biosciences, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 17:08
FBRX Forte Biosciences, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 17:11
FBRX Forte Biosciences, Inc. 12 May 2022 0 $0 3 Director 16 May 2022, 17:08
DRNA Dicerna Pharmaceuticals Inc 28 Dec 2021 5 -$127K 4 Director 29 Dec 2021, 15:19
DRNA Dicerna Pharmaceuticals Inc 03 Jun 2021 4 $0 4 Director 07 Jun 2021, 21:32